Introduction
At the 2014 International AIDS Conference in Melbourne, the United Nations Joint
Program on HIV / AIDS (UNAIDS) has proposed four major strategies to speed up efforts to end the AIDS epidemic as a public health threat by 2030. First, prevention of new HIV infections. Secondly, getting people tested and diagnosed, treating everyone immediately, and keeping patients under care. Thirdly, issues around the best possible choice and efficacy of antiretroviral therapy (ART) and possible toxicities of ART are not to be underestimated.
Lastly, comorbidities associated with HIV must not be forgotten [1] . In this aspect monitoring of function of some organs, especially vulnerable to damage during the treatment and course of disease is important. It has long been recognized that patients with HIV infection are at particular risk of renal disease, although the pattern of disease has changed significantly over the time. The risk of acute and chronic kidney disease (CKD) remains higher in HIV-infected persons than in the general population. It is mentioned that kidney disease in such patients is associated with poor outcomes, including increased mortality [2] . In recent years, a steady increase of the number of HIV-infected patients with CKD as co-morbid complication is observed. It is estimated that up to 30% of HIV infected patients may have kidney function disorders [3, 4] . HIV-associated nephropathy (HIVAN) was considered to be one of the main causes of CKD in these patients. Currently, even though HIVAN occurs less frequently in the era of effective antiretroviral therapy, the HIV immune complex kidney disease has been diagnosed more frequently. The introduction of effective ART resulted in a reduction of the incidence of HIV related end-stage kidney disease (ESRD) [2, 5, 6] . Other nephropathies in which pathogenesis is associated with HIV infection are thrombotic microangiopathy or kidney disease associated with immune complexes called IgA nephropathy [7] . On the other hand, the studies also shown that the ART should be mentioned as important factor connected with the risk of the development of kidney injury, including interstitial nephritis, severe proximal tubulopathy, crystalluria, mitochondrial toxicity, Falcone's syndrome [8] .
It is indicated that CKD will probably be an increasing medical problem in HIVinfected patients. It has been found that both mesangial cells in the glomerulus and tubular epithelial cells are susceptible to invasion by HIV, but also capable of supporting virus replication. It is assumed that kidney damage results directly from HIV infection and is associated with the expression of viral genes, especially Nef and Vpr in kidney epithelial cells, leading to their apoptosis [9] [10] [11] [12] . It has also been proven that the virus can survive in renal epithelial cells, despite the use of ART [2, 3] . Other important factors affecting the development of CKD include: frequent co-infections of HBV (hepatitis B virus) and HCV (hepatitis C virus), intravenous use of narcotic drugs, and opportunistic pathogens, among which CMV (cytomegalovirus hominis), EBV (Epsteina-Barr virus) and VZV (Varicella zoster virus) are the most often associated with renal pathology [13, 14] . Neither can we disregard the nephrotoxic action of antiretroviral drugs and those used in the treatment of opportunistic infections [15] . There are also significant comorbidities which are not a direct consequence of HIV infection, such as diabetes, hyperlipidemia and dyslipidemia, atherosclerosis and high blood pressure [16] .
The complex clinical picture of HIV infection with applied multidirectional therapy requires constant CKD assessment, especially in the subclinical state, along with monitoring of its progression. Clinical need prompts researchers to look for methods facilitating the early identification of HIV-infected patients at risk of renal failure. The best solution seems to be the determination of as large a number of specific parameters as possible (a panel), to detect even the smallest kidney dysfunctions as soon as possible, and additionally indicate the lesion sites (glomerulus, tubules proximal, distal). Recent reports in the world literature indicate high interest in the CKD problem in HIV-infected people [17] .
In March 2017, a multidisciplinary panel of clinical and scientific experts, affiliated to the group of Kidney Disease: Improving Global Outcomes (KDIGO), which was working to identify and discuss key issues relevant to the optimal diagnosis and management of kidney disease in HIV-positive individuals, clearly indicated that renal function in HIV-patients needs to be extensively monitored in order to identification of kidney disease, especially during early stages of disturbances of their function [17] . In this light, to meet the expectations of clinicians, an attempt was made to create a broad panel of biochemical parameters characterizing kidney dysfunctions that may be measured in the urine of HIVpatients, which emphasize the non-invasive nature of this study. The activity of the studied enzymes: NAG, NAG-B, GAL, β-GR, AAT and GGP, were determined in the urine spectrophotometrically, using appropriate substrates according to the methods described by Jung and al. [18] . 
Statistical analysis
Statistical analysis was conducted with Statistica PL software (version 13.3).
Normality of distribution was checked Kolmogorov-Smirnov test with Lillieforce. The MannWhitney U test was used for nonparametric data. The associations between continuous variables were analyzed by the nonparametric Spearman test. The area under the curve (AUC) and the cut-off points were calculated employing ROC analysis, which evaluates the relationship between the sensitivity and specificity of the examined parameters. ROC curves for parameters are presented along with the determined optimal cut-off points (the Youden method).
Additionally, logistic regression analysis was carried out for each parameter separately, and the odds ratios (OR) and confidence intervals (CI) were also determined. The creation of a multifactor model was conducted using stepwise forward logistic regression analysis, and the Hosmer-Lemeshow test and the Wald test were used to evaluate the model. The values of p<0.05 were considered as statistically significant.
Results
The mean values of enzyme activities (NAG, NAG-B, β-GR, GAL, AAT, GGP) and the mean values of concentration of low molecular weight proteins (KIM-1, NGAL, GST-α, GST-π, NPT, β2M, RBP), with standard deviations, as well as medians and range values, in HIV-patients and the control group, are presented in Table 2 and Table 3 , respectively.
The activity of all enzymes in the urine of HIV-patients was significantly higher than in the control group, except for AAP. The highest difference was revealed for NAG, their activity was about 2.2-times higher than in the control group. The next largest differences were observed for: NAG-B (1.5-times increase in activity), β-GR and GGT (1.4-times increase in activity) and GAL (1.3-times increase in activity) ( Table 2 ).
The concentration of all low molecular weight proteins in the urine of HIV-patients were significantly higher in comparison to the control group. The highest significant values in the studied group rather than in the control (Table 3) were noticed for β2M (about 3.8-times).
Additionally, the concentration of NGAL was about 2.7-times higher, and KIM-1 about 1.9-times higher, compared to the control group. Correlation analyses were made between all the examined parameters and the obtained results are presented in Table 4 . The strongest correlations were revealed for the following parameters: GST-α vs GGT (R=0.62), AAP vs GGT (R=0.64), GST-α vs GST-π (R=0.69), NAG vs NAG-B (R=0.70), β-GR vs GGT (R=0.81).
Correlations between the urinary levels of the examined enzymes (NAG, NAG-B, β-GR, GAL, AAT, GGP ) and low-molecular weight proteins (KIM-1, NGAL, GST-α, GST-π, NPT, β2M, RBP) and serum creatinine concentration in HIV-patients were also examined.
Positive moderate correlations with serum creatinine showed only for NPT (R=0.41, P<0.001) and β2M (R=0.33, P<0.001). Correlation with the age of HIV-patients was demonstrated only for KIM-1 (R= 0.23, P=0.03). Table 5 shows selected parameters (β2M, NAG, NGAL, KIM-1 and RBP) having the highest values of the AUC as well as the sensitivity and the specificity.The qualitative comparative assessments of the obtained AUCs under the ROC curves for these selected parameters are shown in the combined graph (Fig 1) .
Results of the univariate logistic regression analysis for all parameters are presented in Table 6 . In the course of logistic regression analysis, the parameters that best characterize kidney dysfunction in HIV-patients were selected from the whole panel being tested. NAG (OR=19.06), β2M (OR=13.65), KIM-1 (OR=9.21) and RBP (OR=7.41) were specified as the best indicators for the predicted risk probability of renal dysfunction in HIV-patients (Table 7) . replication. Significantly, the kidneys act as a virus reservoir [19] . Due to an observed increase in the incidence of CKD in HIV-patients, diagnosis of renal function is necessary to monitor the course of the disease, as well as to prevent the development of ESRD and optimize ongoing antiretroviral therapy. In our study the utility of thirteen selected biochemical markers of kidney function -enzymes and low molecular proteins (NAG, NAG-B, β-GR, GAL, AAT, GGP KIM-1, NGAL, GST-α, GST-π, NPT, β2M and RBP) -were determined non-invasively in the urine of HIV-infected people, in order to determine their potential diagnostic value in the assessment of renal dysfunction of these patients. To our best knowledge, such a complex parameters panel has not previously been examined in HIVpatients. Statistically significant differences between the values of the examined parameters were observed, with the exception of APP, in HIV-patients in relation to the control group (Table 2 and 3) . The available scientific literature data shows that lysosomal enzymes (NAG, NAG-B, β-GR, GAL) and brush border enzymes (AAP, GGT) have been used in the assessment of renal tubular function [20, 21] . In the case of the action of some drugs and nephrotoxic compounds, as well as during disease processes, inflammations, and mechanical injuries, lysosomal membrane permeability often occurs. The consequence of this disturbance is the release of enzymes, primarily located in the organelles, and the increase of their activity in the urine reflects renal tubular dysfunction [2, 20] .
On the basis of the conducted analyses, we observed that among the lysosomal enzymes, the greatest value in the assessment of renal dysfunction in HIV-patients was shown by NAG. In addition, a statistically significant correlation between the NAG and the NAG-B isoenzymes (R = 0.7) was found. NAG is present in free form in lysosomes, and while the NAG-B isoform is bound to the lysosome membranes, its release is the result of damage to structures within the proximal renal tubules [21, 22] . NAG is a useful marker for the early diagnosis of CKD. In addition, it is a sensitive and early indicator in the assessment of pathological changes in kidneys exposed to nephrotoxic xenobiotics [23] . The increased release of enzymes from the lysosomal tubular epithelial cells found in our studies may provide information about the ongoing inflammatory process in the kidneys, during which the number of lysosomes in the tubular cells increases, reflecting the defense mechanisms of the kidney cells.
Ando et al. [24] in a study of HIV-patients with implemented cART therapy, based on the increase in activity of NAG and GGT, showed damaged renal tubules in 25% of the subjects. Moreover, they showed a correlation between tubular damage and the duration of therapy as well as CRP acute phase protein, which indicates inflammation. In our research, a correlation between NAG and GGT (R=0.49) was also demonstrated. The source of the presence of AAP and GGT in the urine is the brush border of the proximal renal tubule. AAP is surface-localized, while GGT is associated with cytoplasmic cell membranes. Damage to cells or their membranes as a result of the action of xenobiotics or drugs, in the course of various diseases or hypoxia, causes the direct release of enzymes into the urine [25, 26] . The significant correlation between these enzymes (R = 0.64) demonstrated in the presented study may indicate damage to the brush border of the proximal tubules.
Analyzing the concentrations of the examined low molecular proteins, we observed that they were statistically significantly higher in HIV-patients compared to the control group. The largest differences were found for: KIM-1, NGAL and β2M (Table 3) , by 54%, 37% and 26%, respectively. The KIM-1 protein is probably involved in the transformation of renal epithelial cells into phagocytes, which alleviates the inflammatory reaction. KIM-1 is intensively expressed and increases synthesis in response to damage to the renal tubules, especially in the S3 segment of the proximal renal tubules, in the outer core layer, which is particularly sensitive to ischemia [27, 28] . Experimental data suggest that KIM-1 may play a role in restoring the function and morphological integrity of renal epithelial cells in response to damage, which makes this protein very interesting as an indicator of renal function [29] [30] [31] .
Bonventre et al. [32] found an increase of KIM-1 expression in response to nephrotoxins: tetrafluoroethyl-1-cysteine (TFEC), folic acid and cisplatin. A study by Gil'a et al. [33] showed an increase in KIM-1 concentration after paraquat intoxication. An increase in KIM-1 was also observed after administration of gentamycin, inorganic mercury or chromium (VI) to rats. This increase was dependent on the degree of histopathological changes in the kidney, and was ahead of the increase of serum creatinine [34] . In our own studies, it was shown that only KIM-1 correlated with the age of HIV-patients. Along with ageing in the kidneys, there are structural and functional changes. Microscopic images show a reduction in the number of active nephrons. The concentration of KIM-1 in the urine is closely related to the level of tissue KIM-1 and correlates with the degree of damage in renal tissue [29] .
The occurrence of NGAL in the tubule kidney cortex, blood and urine is increased upon exposure to ischemia or nephrotoxic agents [35] . Increased NGAL presence in the urine is caused by impaired absorption resulting from the destruction of the proximal tubules.
Detection of this protein in the urine may also contribute to increased de novo synthesis of NGAL in further nephron segments, particularly in the loop of Henle and the collecting tubule [36] . In studies carried out by Sola-Del Valle et al. [37] , a significantly elevated urinary NGAL concentration was observed in patients with HIVAN compared to kidney diseases of a different etiology, which indicates the usefulness of these markers in identifying HIV-related nephropathy.
Measurement of β2M excretion is used to determine the functioning of the renal tubules in response to the action of nephrotoxic compounds. Examination of the level of this protein can also be applied to monitoring kidney function after exposure to cytostatic drugs that are nephrotoxic (e.g. cyclophosphamide, cisplatin). It is suggested that β2M may have diagnostic significance during treatment with gold salts and cyclosporine. There are also reports that β2M may be an indicator of nephropathy caused by analgesic overdoses as well as possibly being helpful in monitoring aminoglycoside nephrotoxicity. Elevated concentrations of β2M are recorded in Sjögren's syndrome, systemic lupus erythematosus, rheumatoid arthritis, Crohn's disease, and AIDS, where the level of the marker increases with the progress of the disease [38, 39] .
RBP is easily filtered in the glomerulus and is almost completely reabsorbed in the proximal tubule. Even slight impairment of the renal tubule can lead to its increased urinary excretion [40, 41] . In the studies of Kuźniar et al. [42] , it was found that increase in urinary excretion of RBP may be due to interstitial damage and not due to a decrease in the number of active nephrons, which would be confirmed by the lack of correlation between RBP excretion and serum creatinine concentration in this group. Also, in our study, there was no significant correlation between urinary concentrations of RBP in the group of HIV patients with serum creatinine concentration. RBP can also be used as a marker of tubulo-interstitial lesion in the course of systemic diseases, including hypertension [43] . Increased levels of RBP were also recorded in the urine of patients with membrane-proliferative glomerulonephritis. Cohen et al. [44] found that the protein RBP may be considered as a uremic toxin contributing to disorders of the immune response in patients with acute renal injury.
Increased occurrence of glutathione transferases (GST-α and GST-π) in the urine after exposure to nephrotoxic agents is explained by the excessive permeability of the renal tubular epithelium due to cell damage. There was a correlation between the urinary activity of glutathione transferases and acute tubular damage also in other states of kidney damage, for example in diabetic nephropathy [45] . It has been shown that the level of GST-α is significantly elevated in HCV-infected patients compared to control [46, 47] . In our study we showed a strong, significant correlation (R=0.69) between the two isoforms of GST-α and GST-π, which confirms the dysfunction of the proximal tubular (location of GST-α), as well as providing further evidence of the disorders' tubular function and the loop of Henle (localization of GST-π ) in HIV-patients.
An important but non-specific marker of HIV infection is neopterin [48] . Assessment of the concentration of this indicator is valuable when monitoring the course of infection, because patients in the asymptomatic period of the disease have a chronically elevated concentration of neopterin, while much higher values are achieved in patients with disease progression who develop full-blown AIDS [49] . An elevated concentration of neopterin is detectable in the early stages of HIV infection, while many other biochemical markers remain at normal levels. It is indicated that assessment of the concentration of NPT is very useful when monitoring the course of HIV infection [50] . In our study, there was a significant 
